Clinical Trials Browser

Phase 2 × Biliary Cancer Metastatic × Irinotecan × Clear all

NCT07062536 2025-07-14

mFOLFOX/mFOLFIRI vs. mFOLFOX in Advanced or Recurrent Biliary Tract Cancer Second-line

Phase 2 Not yet recruiting

Gastrointestinal

Biliary Cancer Metastatic